HomeHeartFlow

HeartFlow

NICE Renews Support for Use of AI-powered HeartFlow

NICE has found that the HeartFlow Analysis continues to improve patient experience and reduce the need for invasive angiography, four years after its initial recommendation that the technology be used to support CHD diagnosis within the NHS.

HeartFlow Reports New JAMA Network Open Publication Demonstrates the Coronary CT- HeartFlow Analysis Pathway Is ‘Dominant’ Compared to Stress Testing in Cost-Effectiveness Analysis

To evaluate clinical effectiveness, the authors looked at lifetime rates of heart attack and death, as well as efficiency of patient selection for invasive diagnostic coronary angiography (ICA) and revascularization, such as a stent procedure or bypass surgery. The authors found that compared to stress testing, coronary CTA with the HeartFlow Analysis improved by 50% the efficiency of selecting patients for invasive testing who then required coronary stenting or bypass procedures.

HeartFlow Planner Receives FDA Clearance

The HeartFlow Planner will enable interventional cardiologists to virtually model clinical scenarios vessel-by-vessel, explore treatment strategies for patients with CAD before each procedure, review cases with colleagues, and ensure everyone has a clear picture of the initial treatment plan.

New Survey Reports Fewer than 1/3 of Americans Know Biggest Health Threat – Heart Disease

2/7/19: The research shows that while most people are optimistic about new health innovations, anxieties and fear may prevent people from seeking effective treatment for their heart health.

HeartFlow Announces Its Novel, Non-Invasive FFRct Technology for Coronary Artery Disease Receives Positive Review from Blue Cross Blue Shield

HeartFlow reports reports this non-invasive technology is the first to provide insight into both the extent of coronary artery disease (CAD) and the impact the disease has on blood flow to the heart.